Janus Henderson Group’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
ACM
KGAMU
JCM
Janus Henderson Group's CDLX Position: Q2 2022 in Review
Janus Henderson Group sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 644 shares — an estimated $355K sold.
Janus Henderson Group first reported a position in CDLX in Q3 2021 and held it in 3 quarters. The position peaked at $426K in Q4 2021. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.
- Janus Henderson Group reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
- Janus Henderson Group sold 644 Cardlytics shares in Q2 2022, an estimated $355K.
- Janus Henderson Group first reported a position in Cardlytics in Q3 2021 and held it in 3 quarters.
- Janus Henderson Group's Cardlytics position peaked at $426K in Q4 2021.
- 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.
Based on Janus Henderson Group's 13F filing for Q2 2022, filed 15 Aug 2022.